Cargando…

Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes

Tau protein is a known contributor in several neurodegenerative diseases, including Alzheimer’s disease (AD) and frontotemporal dementia (FTD). It is well-established that tau forms pathological aggregates and fibrils in these diseases. Tau has been observed within the nuclei of neurons, but there i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montalbano, Mauro, Jaworski, Elizabeth, Garcia, Stephanie, Ellsworth, Anna, McAllen, Salome, Routh, Andrew, Kayed, Rakez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678415/ https://www.ncbi.nlm.nih.gov/pubmed/34924950 http://dx.doi.org/10.3389/fnmol.2021.742790

Ejemplares similares

Auto- and cross-regulation of the hnRNPs D and DL
por: Kemmerer, Katrin, et al.
Publicado: (2018)

The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis
por: Bampton, Alexander, et al.
Publicado: (2020)

Research Progress on the Structural and Functional Roles of hnRNPs in Muscle Development
por: Li, Zhenyang, et al.
Publicado: (2023)

Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS
por: Kim, Hong Joo, et al.
Publicado: (2013)

hnRNPs and ELAVL1 cooperate with uORFs to inhibit protein translation
por: Zhang, Jiewen, et al.
Publicado: (2017)

Combinatorial control of Drosophila circular RNA expression by intronic repeats, hnRNPs, and SR proteins
por: Kramer, Marianne C., et al.
Publicado: (2015)

SARS‐CoV‐2 nucleocapsid protein phase‐separates with RNA and with human hnRNPs
por: Perdikari, Theodora Myrto, et al.
Publicado: (2020)

Viral DNA Replication Orientation and hnRNPs Regulate Transcription of the Human Papillomavirus 18 Late Promoter
por: Wang, Xiaohong, et al.
Publicado: (2017)

Tau oligomers mediate aggregation of RNA‐binding proteins Musashi1 and Musashi2 inducing Lamin alteration
por: Montalbano, Mauro, et al.
Publicado: (2019)

Pan‐cancer analysis of alternative splicing regulator heterogeneous nuclear ribonucleoproteins (hnRNPs) family and their prognostic potential
por: Li, Hao, et al.
Publicado: (2020)

A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1
por: Geissler, Rene, et al.
Publicado: (2016)

Nuclear RNA export factor 7 is localized in processing bodies and neuronal RNA granules through interactions with shuttling hnRNPs
por: Katahira, Jun, et al.
Publicado: (2008)

KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer
por: Varlı, Mücahit, et al.
Publicado: (2023)

Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies
por: Puangmalai, Nicha, et al.
Publicado: (2020)

TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A
por: Koike, Yuka, et al.
Publicado: (2023)

Heterochromatin Protein 1 (HP1a) Positively Regulates Euchromatic Gene Expression through RNA Transcript Association and Interaction with hnRNPs in Drosophila
por: Piacentini, Lucia, et al.
Publicado: (2009)

Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells
por: Kang, Xuedong, et al.
Publicado: (2008)

Correction: TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A
por: Koike, Yuka, et al.
Publicado: (2023)

High Throughput FISH Screening Identifies Small Molecules That Modulate Oncogenic lncRNA MALAT1 via GSK3B and hnRNPs
por: Zablowsky, Nina, et al.
Publicado: (2023)

Modulating disease-relevant tau oligomeric strains by small molecules
por: Lo Cascio, Filippa, et al.
Publicado: (2020)

The quadruplex r(CGG)(n) destabilizing cationic porphyrin TMPyP4 cooperates with hnRNPs to increase the translation efficiency of fragile X premutation mRNA
por: Ofer, Noa, et al.
Publicado: (2009)

RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction
por: Montalbano, Mauro, et al.
Publicado: (2020)

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease
por: Sengupta, Urmi, et al.
Publicado: (2018)

T cell LFA-1-induced proinflammatory mRNA stabilization is mediated by the p38 pathway kinase MK2 in a process regulated by hnRNPs C, H1 and K
por: Rao, Gautham K., et al.
Publicado: (2018)

Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer’s disease and frontotemporal dementia
por: Gaikwad, Sagar, et al.
Publicado: (2021)

Identification of heterogenous nuclear ribonucleoproteins (hnRNPs) and serine- and arginine-rich (SR) proteins that induce human papillomavirus type 16 late gene expression and alter L1 mRNA splicing
por: Hao, Chengyu, et al.
Publicado: (2021)

Neurotoxic tau oligomers after single versus repetitive mild traumatic brain injury
por: Bittar, Alice, et al.
Publicado: (2019)

Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer’s disease
por: Puangmalai, Nicha, et al.
Publicado: (2022)

Variant snRNPs: New players within the spliceosome system
por: Vazquez-Arango, Pilar, et al.
Publicado: (2017)

Core spliceosomal Sm proteins as constituents of cytoplasmic mRNPs in plants
por: Hyjek‐Składanowska, Malwina, et al.
Publicado: (2020)

Association of individual hnRNP proteins and snRNPs with nascent transcripts
Publicado: (1993)

Formation and Propagation of Tau Oligomeric Seeds
por: Gerson, Julia E., et al.
Publicado: (2013)

Splicing-independent recruitment of spliceosomal small nuclear RNPs to nascent RNA polymerase II transcripts
por: Patel, Snehal Bhikhu, et al.
Publicado: (2007)

Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives
por: Lo Cascio, Filippa, et al.
Publicado: (2019)

Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies
por: Montalbano, Mauro, et al.
Publicado: (2022)

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
por: Farmer, Kathleen M., et al.
Publicado: (2020)

Advances and considerations in AD tau-targeted immunotherapy
por: Bittar, Alice, et al.
Publicado: (2019)

Tau Protein: Function and Pathology
por: Rosenmann, Hanna, et al.
Publicado: (2012)

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease
por: Marcatti, Michela, et al.
Publicado: (2022)

The Sm-core mediates the retention of partially-assembled spliceosomal snRNPs in Cajal bodies until their full maturation
por: Roithová, Adriana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_28juvhk64r5g22gi4vok9i7ssp